Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod Rocco CapuanoManuela AltieriAntonio Gallo Original Communication Open access 26 July 2022 Pages: 6185 - 6192
BNT162b2 mRNA COVID-19 vaccine three-dose safety and risk of COVID-19 in patients with myasthenia gravis during the alpha, delta, and omicron waves Alon DoronYoav PiuraArnon Karni Original Communication 30 July 2022 Pages: 6193 - 6201
The late onset of emotional distress in people with progressive multiple sclerosis during the Covid-19 pandemic: longitudinal findings from the CogEx study Anthony FeinsteinMaria Pia Amatothe CogEx Research Team Original Communication 08 August 2022 Pages: 6202 - 6210
Referral trajectories in patients with vertigo, dizziness and balance disorders and their impact on health-related quality of life and functioning: results from the longitudinal multicenter study MobilE-TRA Benedict KatzenbergerDaniela KollerEva Grill Original Communication Open access 30 March 2022 Pages: 6211 - 6221
Downbeat nystagmus becomes attenuated during walking compared to standing Haike DietrichCauchy PradhanMax Wuehr Original Communication Open access 12 April 2022 Pages: 6222 - 6227
Influence of stance width on standing balance in healthy older adults Stephanie SchmidleAlexandra Charlotte de CrignisCarmen Krewer Original Communication Open access 09 May 2022 Pages: 6228 - 6236
Vestibular paroxysmia: clinical characteristics and long-term course Karoline SteinmetzSandra Becker-BenseDoreen Huppert Original Communication Open access 20 May 2022 Pages: 6237 - 6245
Outcome of vestibular rehabilitation in vestibular migraine Birgul BalciGülden Akdal Original Communication 08 July 2022 Pages: 6246 - 6253
A systematic review of digital technology to evaluate motor function and disease progression in motor neuron disease Emily BeswickThomas FawcettSuvankar Pal Review Open access 09 August 2022 Pages: 6254 - 6268
Cognitive impairment in psoriasis patients: a systematic review of case–control studies Daniel PankowskiK. Wytrychiewicz-PankowskaW. Owczarek Review Open access 09 August 2022 Pages: 6269 - 6278
The relationship between body mass index and stroke: a systemic review and meta-analysis Xinyu WangYanan HuangYuxia Ma Review 15 August 2022 Pages: 6279 - 6289
Recent applications of quantitative electroencephalography in adult intensive care units: a comprehensive review Jaeho HwangSung-Min ChoEva K. Ritzl Review 19 August 2022 Pages: 6290 - 6309
Transcranial direct current stimulation in neglect rehabilitation after stroke: a systematic review B. González-RodriguezN. Serradell-RibéElena M. Marron Review Open access 22 September 2022 Pages: 6310 - 6329
Elevated inflammatory biomarkers and poor outcomes in intracerebral hemorrhage Edward R. BaderTiberiu A. PanaPhyo K. Myint Original Communication Open access 22 July 2022 Pages: 6330 - 6341
Incidence and risk factors of epilepsy following brain arteriovenous malformation rupture in adult patients Gonzague GuillaumetEimad ShotarBertrand Mathon Original Communication 22 July 2022 Pages: 6342 - 6353
Unravelling the etiology of sporadic late-onset cerebellar ataxia in a cohort of 205 patients: a prospective study T. BogdanT. WirthM. Anheim Original Communication 23 July 2022 Pages: 6354 - 6365
Characteristic retinal atrophy pattern allows differentiation between pediatric MOGAD and MS after a single optic neuritis episode T. PakeerathanJ. HavlaI. Ayzenberg Original Communication Open access 23 July 2022 Pages: 6366 - 6376
Plasma biomarkers inclusive of α-synuclein/amyloid-beta40 ratio strongly correlate with Mini-Mental State Examination score in Parkinson’s disease and predict cognitive impairment Daniel Kam Yin ChanJack ChenGeorge D. Mellick Original Communication Open access 25 July 2022 Pages: 6377 - 6385
Dysregulation of peripheral monocytes and pro-inflammation of alpha-synuclein in Parkinson’s disease Yun SuChanghe ShiYuming Xu Original Communication 27 July 2022 Pages: 6386 - 6394
Risk factors and outcome of hyperammonaemia in people with epilepsy Angeliki VakrinouElaine MurphySimona Balestrini Original Communication Open access 30 July 2022 Pages: 6395 - 6405
Genetic spectrum and founder effect of non-dystrophic myotonia: a Japanese case series study Jun-Hui YuanYujiro HiguchiHiroshi Takashima Original Communication 30 July 2022 Pages: 6406 - 6415
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update Thomas H. BrannaganTeresa Coelhofor the NEURO-T. T. R. Open-Label Extension Investigators Original Communication Open access 31 July 2022 Pages: 6416 - 6427
A score to predict the stroke recurrence of patients with embolic stroke of undetermined source Jing JingXiaomeng YangYongjun Wang Original Communication 04 August 2022 Pages: 6428 - 6435
Clinical and genotypic analysis in determining dystonia non-motor phenotypic heterogeneity: a UK Biobank study Megan E. WadonEilidh FennerKathryn J. Peall Original Communication Open access 04 August 2022 Pages: 6436 - 6451
Associated factors and abnormal dorsal raphe nucleus connectivity patterns of freezing of gait in Parkinson’s disease Lingling LvHainan ZhangChunyu Wang Original Communication 06 August 2022 Pages: 6452 - 6466
Impact of delirium on the outcome of stroke: a prospective, observational, cohort study Eleonora RolloValerio BrunettiGiacomo Della Marca Original Communication Open access 09 August 2022 Pages: 6467 - 6475
Novel phenotype with prominent cerebellar oculomotor dysfunction in spastic paraplegia type 39 Sebastian ViertauerIngo KurthChristian Eggers Original Communication Open access 10 August 2022 Pages: 6476 - 6482
The epidemiology of dystonia: the Hannover epidemiology study Dirk DresslerEckart AltenmüllerFereshte Adib Saberi Original Communication Open access 11 August 2022 Pages: 6483 - 6493
Identification of high-risk intracranial plaques with 3D high-resolution magnetic resonance imaging-based radiomics and machine learning Hongxia LiJia LiuGuangming Lu Original Communication 11 August 2022 Pages: 6494 - 6503
Persistence, adherence, healthcare resource utilization and costs for ocrelizumab in the real-world of the Campania Region of Italy Marcello MocciaGiuseppina AffinitoRaffaele Palladino Original Communication Open access 11 August 2022 Pages: 6504 - 6511
Association of rare variants in genes of immune regulation with pediatric autoimmune CNS diseases Saba JafarpourAbhik BanerjeeJonathan D. Santoro Original Communication 12 August 2022 Pages: 6512 - 6529
A task-specific cognitive domain decline is correlated with plasma and neuroimaging markers in patients with Parkinson’s disease Cheng-Hsuan LiTa-Fu ChenChin-Hsien Lin Original Communication 14 August 2022 Pages: 6530 - 6543
Cost-effectiveness analysis of gene-based therapies for patients with spinal muscular atrophy type I in Australia Tianjiao WangPaul ScuffhamMartin Downes Original Communication Open access 18 August 2022 Pages: 6544 - 6554
Primary mitochondrial myopathy: 12-month follow-up results of an Italian cohort V. MontanoP. LoprioreMichelangelo Mancuso Original Communication Open access 18 August 2022 Pages: 6555 - 6565
Wearable motion sensors to track tremor changes after radiosurgical thalamotomy Luigi AlbanoDaniele EmedoliMassimo Filippi Original Communication 20 August 2022 Pages: 6566 - 6571
Usefulness of subcutaneous immunoglobulin therapy in the management of myasthenia gravis: a retrospective cohort study Marlène BarnayFanny DuvalGwendal Le Masson Original Communication 22 August 2022 Pages: 6572 - 6581
Olfactory dysfunction is common in classical infratentorial superficial siderosis of the central nervous system Natallia KharytaniukE. A. LimD. E. Bamiou Original Communication Open access 23 August 2022 Pages: 6582 - 6588
Clinical and neuroimaging risk factors associated with the development of intracerebral hemorrhage while taking direct oral anticoagulants Alvin S. DasElif GökçalM. Edip Gurol Original Communication 23 August 2022 Pages: 6589 - 6596
Generalization of ocular myasthenia gravis 10 years after onset Antoine GuéguenBenoit HijaziOlivier Gout Original Communication 24 August 2022 Pages: 6597 - 6604
Microembolic signals and antiplatelet therapy in Moyamoya angiopathy Mosche PompschRoland VeltkampMarkus Kraemer Original Communication 24 August 2022 Pages: 6605 - 6612
Atypical Alzheimer’s disease phenotypes with normal or borderline PET biomarker profiles Neha Atulkumar SinghJonathan Graff-RadfordJennifer L. Whitwell Original Communication 24 August 2022 Pages: 6613 - 6626
Visual hallucinosis during hypoperfusion of the right occipito-temporal cortex Nicolae SandaJose Bernardo Escribano ParedesVictor Ferastraoaru Original Communication Open access 24 August 2022 Pages: 6627 - 6633
Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington’s disease Sonia Di TellaMaria RIta Lo MonacoAnna Rita Bentivoglio Original Communication 01 August 2022 Pages: 6634 - 6640
Correction to: Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington’s disease Sonia Di TellaMaria Rita Lo MonacoAnna Rita Bentivoglio Correction 07 October 2022 Pages: 6641 - 6641
Acute vertical pendular nystagmus: eye-movement analysis and review of the literature Eun Hye OhHyun Sung KimJae-Hwan Choi Short Commentary 29 July 2022 Pages: 6642 - 6647
Nonregional small fibre neuropathy in cases of autoimmune autonomic neuropathy Andrea MaierRomina KapfenbergerRoman Rolke Short Commentary Open access 09 September 2022 Pages: 6648 - 6654
Cobalt intoxication: mitochondrial features and condition Christine HeuerAnne-Catherine StreitHans H. Jung Letter to the Editors 04 July 2022 Pages: 6655 - 6657
Repeated erythema and pain in the lateral thoracic region due to spinal cord infarction: a case report Tomomichi KitagawaKenichiro SakaiYasuyuki Iguchi Letter to the Editors 07 July 2022 Pages: 6658 - 6660
A very early onset of juvenile parkinsonism Luca MagistrelliElena ContaldiCristoforo Comi Letter to the Editors 18 July 2022 Pages: 6661 - 6663
Next-generation sequencing: a decisive diagnostic aid for atypical Wilson’s disease Amory JardelCéline BonnetMathilde Renaud Letter to the Editors 21 July 2022 Pages: 6664 - 6666